Zions Trust National Association’s Novartis NVS Stock Holding History

Zions Trust National Association’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	$28K	Hold	335	–	–	0.04%	122
2014 Q3	$28K	Hold	335	–	–	0.04%	118
2014 Q2	$27K	Sell	335 -212	-39%	-$16.7K	0.04%	124
2014 Q1	$42K	Buy	547 +335	+158%	+$24.4K	0.06%	100
2013 Q4	$15K	Buy	+212	New	+$14.7K	0.02%	151

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $22.8B AUM 25.09% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BTS

BB&T Securities Richmond, Virginia $10.9B AUM 16.21% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

MAA

Managed Account Advisors Jersey City, New Jersey $121B AUM 7.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Zions Trust National Association's NVS Position: Q4 2014 in Review

Zions Trust National Association held its Novartis (NVS) position steady in Q4 2014 at 335 shares worth $28K. The position accounts for 0.04% of the portfolio, ranked #122.

Zions Trust National Association first reported a position in NVS in Q4 2013 and has held it in 5 quarters since. The position peaked at $42K in Q1 2014. 919 funds tracked by Wall St. Rank hold NVS as of Q4 2014.

Zions Trust National Association held 335 shares of Novartis worth $28K as of Q4 2014.
Zions Trust National Association left its Novartis share count unchanged in Q4 2014.
Novartis made up 0.04% of Zions Trust National Association's portfolio in Q4 2014, its #122 holding.
Zions Trust National Association first reported a position in Novartis in Q4 2013 and has held it in 5 quarters since.
Zions Trust National Association's Novartis position peaked at $42K in Q1 2014.
919 funds tracked by Wall St. Rank held Novartis as of Q4 2014.

Based on Zions Trust National Association's 13F filing for Q4 2014, filed 12 Jan 2015.